AIM IMMUNOTECH INC. (AIM) Operating margin 2016–2025
AIM IMMUNOTECH INC. (AIM) operating margin by fiscal year — reported operating income divided by reported revenue.
-13254.5%FY2025 · since FY2016: -15004.3% → -13254.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -13254.5% | -1624.0 pp |
| FY2024 | -11630.6% | +4169.4 pp |
| FY2023 | -15800.0% | -1670.2 pp |
| FY2022 | -14129.8% | -175.7 pp |
| FY2021 | -13954.1% | -4658.4 pp |
| FY2020 | -9295.7% | -407.8 pp |
| FY2019 | -8887.9% | -5755.4 pp |
| FY2018 | -3132.4% | -520.1 pp |
| FY2017 | -2612.4% | +12392.0 pp |
| FY2016 | -15004.3% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice